SCHEMBL6598162

SCHEMBL6598162

CCOC(=O)c1cc2cc(-n3cnc(COC(=O)Nc4ccccc4)c3)c(C(F)(F)F)cc2[nH]c1=O

nearest known ligand 0.69

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 3/20 0.61
GRIA2 P42262 3/20 0.61
GRIA3 P42263 3/20 0.61
GRIA4 P48058 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6595494 0.93 GRIA1 (0.64) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6597729 0.92 GRIA1 (0.67) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6596934 0.89 GRIA1 (0.47) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6608183 0.87 GRIA1 (0.75) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6596787 0.85 GRIA1 (0.77) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6595741 0.84 GRIA1 (0.45) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6598565 0.84 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6596409 0.82 GRIA1 (0.57) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6605090 0.82 GRIA1 (0.88) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6602695 0.81 GRIA1 (0.79) GRIA1GRIA2GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1156044-B1 6-SUBSTITUTED HETEROQUINOLINECARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-08-25 EP disclosed
US-6562839-B1 Effective for the therapy of disorder of cerebral nerve cells as antagonists against excitatory amino acid receptors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-05-13 US disclosed
EP-1156044-A1 6-SUBSTITUTED HETEROQUINOLINECARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2001-11-21 EP disclosed